Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — The Food and Drug Administration has just three days until it must finally decide which e-cigarette brands and products — including Juul — can stay on the market.

So far, the agency has only reviewed a small portion of the 6.5 million applications it has received — making it seem highly unlikely that the FDA will be able to cross this particular finish line. The FDA also hasn’t given the judge who set the Sept. 9 deadline any indication that it’s about to miss it, despite the fact that e-cigarette makers, and even another federal agency, have been begging the FDA for extensions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment